Cargando…

The prognostic value of CDKN2A hypermethylation in colorectal cancer: a meta-analysis

BACKGROUND: The prognostic value of CDKN2A promoter hypermethylation in colorectal cancer remains controversial. We systematically reviewed the evidence for assessment of CDKN2A methylation in colorectal cancer to elucidate this issue. METHODS: Pubmed, Embase and ISI web of knowledge were searched t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xing, X, Cai, W, Shi, H, Wang, Y, Li, M, Jiao, J, Chen, M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2013
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3694241/ https://www.ncbi.nlm.nih.gov/pubmed/23703248 http://dx.doi.org/10.1038/bjc.2013.251

Ejemplares similares

Potential diagnostic and prognostic values of detecting promoter hypermethylation in the serum of patients with gastric cancer
por: Leung, W K, et al.
Publicado: (2005)

Expression and prognostic value of transcription factor PROX1 in colorectal cancer
por: Skog, M, et al.
Publicado: (2011)

Hypermethylation-mediated reduction of WWOX expression in intraductal papillary mucinous neoplasms of the pancreas
por: Nakayama, S, et al.
Publicado: (2009)

A cohort study of the prognostic and treatment predictive value of SATB2 expression in colorectal cancer
por: Eberhard, J, et al.
Publicado: (2012)

Comparison of the prognostic value of selected markers of the systemic inflammatory response in patients with colorectal cancer
por: Leitch, E F, et al.
Publicado: (2007)

Prognostic value of circulating tumour cells for early recurrence after resection of colorectal liver metastases
por: Lalmahomed, Z S, et al.
Publicado: (2015)

Loss of imprinting of IGF2 correlates with hypermethylation of the H19 differentially methylated region in hepatoblastoma
por: Honda, S, et al.
Publicado: (2008)

Prognostic and predictive value of common mutations for treatment response and survival in patients with metastatic colorectal cancer
por: Souglakos, J, et al.
Publicado: (2009)

Even-skipped homeobox 1 is frequently hypermethylated in prostate cancer and predicts PSA recurrence
por: Truong, M, et al.
Publicado: (2012)

Somatostatin Receptor 1, a novel EBV-associated CpG hypermethylated gene, contributes to the pathogenesis of EBV-associated gastric cancer
por: Zhao, J, et al.
Publicado: (2013)

Aberrant CDKN1A transcriptional response associates with abnormal sensitivity to radiation treatment
por: Badie, C, et al.
Publicado: (2008)

Clinical prognostic value of combined analysis of Aldh1, Survivin, and EpCAM expression in colorectal cancer
por: Goossens-Beumer, I J, et al.
Publicado: (2014)

Cytoglobin is upregulated by tumour hypoxia and silenced by promoter hypermethylation in head and neck cancer
por: Shaw, R J, et al.
Publicado: (2009)

Frequent deletion of the CDKN2A locus in chordoma: analysis of chromosomal imbalances using array comparative genomic hybridisation
por: Hallor, K H, et al.
Publicado: (2008)

Hypermethylation of multiple genes as clonal markers in multicentric hepatocellular carcinoma
por: Nomoto, S, et al.
Publicado: (2007)

Prognostic significance of CD44 variant 2 upregulation in colorectal cancer
por: Ozawa, M, et al.
Publicado: (2014)

DNA hypermethylation analysis in sputum for the diagnosis of lung cancer: training validation set approach
por: Hubers, A J, et al.
Publicado: (2015)

BRAF mutation is a powerful prognostic factor in advanced and recurrent colorectal cancer
por: Yokota, T, et al.
Publicado: (2011)

ING4 regulates JWA in angiogenesis and their prognostic value in melanoma patients
por: Lu, J, et al.
Publicado: (2013)

Identification of DNA hypermethylation of SOX9 in association with bladder cancer progression using CpG microarrays
por: Aleman, A, et al.
Publicado: (2008)

Hypermethylation of the 5′ CpG island of the gene encoding the serine protease Testisin promotes its loss in testicular tumorigenesis
por: Manton, K J, et al.
Publicado: (2005)

Fasting blood glucose is a novel prognostic indicator for extranodal natural killer/T-cell lymphoma, nasal type
por: Cai, Q, et al.
Publicado: (2013)

MDM2 is an important prognostic and predictive factor for platin–pemetrexed therapy in malignant pleural mesotheliomas and deregulation of P14/ARF (encoded by CDKN2A) seems to contribute to an MDM2-driven inactivation of P53
por: Walter, R F H, et al.
Publicado: (2015)

The status of CDKN2A alpha (p16(INK4A)) and beta (p14(ARF)) transcripts in thyroid tumour progression
por: Ferru, A, et al.
Publicado: (2006)

The use of kallikrein-related peptidases as adjuvant prognostic markers in colorectal cancer
por: Talieri, M, et al.
Publicado: (2009)

Disseminated tumour cells as a prognostic biomarker in colorectal cancer
por: Flatmark, K, et al.
Publicado: (2011)

Comparison of the prognostic value of inflammation-based prognostic scores in patients with hepatocellular carcinoma
por: Kinoshita, A, et al.
Publicado: (2012)

A validated metabolomic signature for colorectal cancer: exploration of the clinical value of metabolomics
por: Farshidfar, Farshad, et al.
Publicado: (2016)

Prognostic value of peritumoral heat-shock factor-1 in patients receiving resection of hepatocellular carcinoma
por: Zhang, J-B, et al.
Publicado: (2013)

Growth differentiation factor 15: a prognostic marker for recurrence in colorectal cancer
por: Wallin, U, et al.
Publicado: (2011)

Prognostic implication of the CpG island methylator phenotype in colorectal cancers depends on tumour location
por: Bae, J M, et al.
Publicado: (2013)

Predictive value of miR-9 as a potential biomarker for nasopharyngeal carcinoma metastasis
por: Lu, J, et al.
Publicado: (2014)

Cytokine profile and prognostic significance of high neutrophil-lymphocyte ratio in colorectal cancer
por: Chen, Z-Y, et al.
Publicado: (2015)

COUP-TFII regulates metastasis of colorectal adenocarcinoma cells by modulating Snail1
por: Bao, Y, et al.
Publicado: (2014)

Molecular heterogeneity and prognostic implications of synchronous advanced colorectal neoplasia
por: Malesci, A, et al.
Publicado: (2014)

ALDH1 is an independent prognostic factor for patients with stages II–III rectal cancer after receiving radiochemotherapy
por: Deng, Y, et al.
Publicado: (2014)

The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis
por: Gooden, M J M, et al.
Publicado: (2011)

Prognostic value of microRNA expression in operable non-small cell lung cancer patients
por: Skrzypski, M, et al.
Publicado: (2014)

PD-1(+) CD8(+) T cells are exhausted in tumours and functional in draining lymph nodes of colorectal cancer patients
por: Wu, X, et al.
Publicado: (2014)

Independent prognostic value of fascin immunoreactivity in stage III–IV colonic adenocarcinoma
por: Puppa, G, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_3g7ocf0c0rn6sknjctp1mtsq79